Surging global adoption of targeted genomic therapies, expanding cell and gene therapy clinical pipelines, and continuous bioprocessing refinements in double-strand-break-free gene editing are driving rapid growth across the global Base Editing Market. Base editing platforms—comprising cytosine base editors (CBEs), adenine base editors (ABEs), and emerging glycosylase base editors...
